Allergies Clinical Trials Doctors Nurses 
The Pharma Data
DECEMBER 2, 2020
Still, the temperature requirement could dictate who will be vaccinated first in Britain: While nursing home residents were supposed to be the top priority under an advisory committee’s plans, efforts to limit transportation of the vaccine may mean that National Health Service staff will receive the shots first, the Times reported.
The Pharma Data
JANUARY 26, 2021
In the trial, the safety profile of bamlanivimab and etesevimab together was consistent with observations from other Phase 1, Phase 2 and Phase 3 trials evaluating these antibodies. Serious adverse events were reported at a similar frequency in the bamlanivimab and etesevimab together and placebo groups.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
DECEMBER 19, 2020
National Institute of Allergy and Infectious Diseases. Moderna’s vaccine was shown to be 94 percent effective in its large clinical trial; Pfizer’s vaccine was 95 percent effective. Doctors say this reflects India’s younger and leaner population. “I believe that’s possible.”
The Pharma Data
DECEMBER 18, 2020
National Institute of Allergy and Infectious Diseases. Moderna’s vaccine was shown to be 94 percent effective in its large clinical trial, while Pfizer’s vaccine was 95 percent effective. Doctors say this reflects India’s younger and leaner population. billion, the Post reported.
The Pharma Data
DECEMBER 21, 2020
. “To get another very important vaccine into play is just, yet again, another step toward what the ultimate goal is: to get enough people vaccinated so you could essentially end the epidemic as we know it in this country,” Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told the Washington Post.
The Pharma Data
DECEMBER 22, 2020
National Institute of Allergy and Infectious Diseases, said Monday. National Institute of Allergy and Infectious Diseases. Moderna’s vaccine was shown to be 94 percent effective in its large clinical trial; Pfizer’s vaccine was 95 percent effective. “It very well might be here for all we know.”
The Pharma Data
DECEMBER 23, 2020
That includes two companies — Sanofi and Novavax — that have yet to begin large clinical trials in the United States. Residents of nursing homes, who have suffered a disproportionate share of COVID-19 deaths, are already getting shots. Doctors say this reflects India’s younger and leaner population.
Expert insights. Personalized for you.
40 
Let's personalize your content